Related Experiment Video
Updated: Sep 26, 2025

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
Published on: March 31, 2019
The CtIP-CtBP1/2-HDAC1-AP1 transcriptional complex is required for the transrepression of DNA damage modulators in
Xun Chen1, Qian Zhang2, Xiaoqian Dang3
1Department of Orthopaedics, Honghui Hospital, Xi'an Jiaotong University, 76 Nanguo Rd, Beilin District, Xi'an, Shaanxi 710054, China; Department of Orthopaedics, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710005, China.
Abstract:
Most tumors, including osteosarcomas, have deficiencies in DNA damage repair. However, the regulatory mechanisms underlying dysregulation of DNA damage repair genes are still being investigated. In this study, we reveal that C-terminal binding protein (CtBP) interacting protein (CtIP) couples with three transcriptional regulators, CtBP1/2 heterodimer, histone deacetylase 1 (HDAC1), and two subunits of the activating protein 1 (AP1) transcription factor to assemble a transcriptional complex. This complex specifically controls the expression of four genes involved in DNA damage and repair processes: MutL homolog 1 (MLH1), MutS Homolog 3 (MSH3), breast cancer type 1 (BRCA1), and cyclin dependent kinase inhibitor 1A (CDKN1A). Chromatin immunoprecipitation (ChIP) assay results revealed that the CtIP-CtBP1/2-HDAC1-AP1 complex regulated these four genes by binding to their promoters through the TGAT/CTCA consensus sequence. The depletion of CtIP, CtBP1/2, and HDAC1 increased the expression levels of MLH1, MSH3, BRCA1, and CDKN1A and inhibited in vitro and in vivo osteosarcoma cell growth. Overexpression of MLH1, MSH3, BRCA1, or CDKN1A in osteosarcoma cells can reduce cell viability, colony formation, cell migration, and tumor growth. Our findings suggest that the CtIP-CtBP1/2-HDAC1-AP1 complex is required for mediation of DNA damage processes for the pathogenesis of osteosarcoma.
Insights
C-terminal binding protein (CtBP) interacting protein (CtIP) forms a complex that regulates DNA repair genes MLH1, MSH3, BRCA1, and CDKN1A. Inhibiting this complex slows osteosarcoma cell growth.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- Tumors, including osteosarcomas, often exhibit impaired DNA damage repair.
- Mechanisms regulating DNA damage repair gene expression are under active investigation.
Purpose of the Study:
- To elucidate the regulatory mechanisms controlling key DNA damage and repair genes in osteosarcoma.
- To identify the role of the CtBP interacting protein (CtIP) in regulating these genes.
Main Methods:
- Chromatin immunoprecipitation (ChIP) assays to identify gene promoter binding.
- Gene expression analysis upon depletion or overexpression of key proteins.
- In vitro and in vivo assays to assess osteosarcoma cell growth and tumor progression.
Main Results:
- CtIP, CtBP1/2, HDAC1, and AP1 form a transcriptional complex regulating MLH1, MSH3, BRCA1, and CDKN1A.
- This complex binds to the TGAT/CTCA consensus sequence in the promoters of these four genes.
- Depletion of CtIP, CtBP1/2, or HDAC1 upregulated MLH1, MSH3, BRCA1, and CDKN1A, inhibiting osteosarcoma cell growth.
- Overexpression of MLH1, MSH3, BRCA1, or CDKN1A reduced osteosarcoma cell viability, migration, and tumor growth.
Conclusions:
- The CtIP-CtBP1/2-HDAC1-AP1 complex is crucial for mediating DNA damage repair processes in osteosarcoma pathogenesis.
- Targeting this complex or its downstream genes presents a potential therapeutic strategy for osteosarcoma.
More Related Videos
Related Concept Videos
Co-activators and Co-repressors
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
TGF - β Signaling Pathway
The Intrinsic Apoptotic Pathway
Master Transcription Regulators

